Home Nucleus Medical Devices Global Lung Cancer Diagnostics Market to 2032

Global Lung Cancer Diagnostics Market to 2032

Overview

The Global Lung Cancer Diagnostics Market is expected to reach a 12,992.36 USD Billion by 2032 and is projected to grow at a CAGR of 15.96% from 2025 to 2032.

Revenue, 2024 (USD Billion)
4,256.32
Forecast, 2032 (USD Billion)
12,992.36
CAGR, 2024 - 2032
15.96%
Report Coverage
Global

Global Lung Cancer Diagnostics Market 2018-2032 USD Billion

Global Lung Cancer Diagnostics Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 4,256.32 USD Billion
  • Projected Market Size (2032): 12,992.36 USD Billion
  • CAGR (2025-2032): 15.96%

Key Findings of Global Lung Cancer Diagnostics Market

  • The Global Lung Cancer Diagnostics Market was valued at 12,992.36 USD Billion in 2024.
  • The Global Lung Cancer Diagnostics Market is likely to grow at a CAGR of 15.96% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Non-Small Cell Lung Cancer in Cancer Segment accounted for the largest share of the market with a revenue of 3,273.59 USD Billion
  • The fastest growing segment Hospital in End User Segment grew Fastest with a CAGR of 17.75% during the forecast period from 2024 to 2032.

Global Lung Cancer Diagnostics Market Scope

Global Lung Cancer Diagnostics Market Segmentation & Scope
Test
  • Blood Test
  • Biopsy
  • Biomarkers Test
  • Others
  • Imaging Test
Cancer
  • Small Cell Lung Cancer
  • Non-Small Cell Lung Cancer
Distribution Channel
  • Retail Sales
  • Direct Tender
End User
  • Others
  • Cancer Research Institutes
  • Diagnostic Imaging Centers
  • Independent Diagnostic Laboratories
  • Associated Labs
  • Hospital
Product
  • Instruments
  • Consumables & Accessories

Global Lung Cancer Diagnostics Market Data Coverage Insights

Study Period 2024-2032
Base Year 2021
Unit Revenue in USD Billion
Market Value in 2024 4,256.32 USD Billion
Market Value in 2032 12,992.36 USD Billion
CAGR (2025-2032) 15.96%
Historic Data 2016-2023
Market Segments Covered Test,Cancer,Distribution Channel,End User,Product

Regional Insights:

  • Leading Market (2024-2032): Global, leading in terms of revenue 4,256.32 USD Billion in 2024
    • Key Country: U.S., leading in terms of revenue with value of 1,915.06 USD Billion in 2024.

Segments and Scope

  • Global Lung Cancer Diagnostics Market to 2032, By Test
    • Imaging Test is the largest segment in Global Lung Cancer Diagnostics Market to 2032 with a revenue of 2,098.01 USD Billion in the year 2024.
    • Imaging Test is the Fastest growing segment in Global Lung Cancer Diagnostics Market to 2032 with a Growth rate of 16.79 % in forecast period 2025-2032.
  • Global Lung Cancer Diagnostics Market to 2032, By Cancer
    • Non-Small Cell Lung Cancer is the largest segment in Global Lung Cancer Diagnostics Market to 2032 with a revenue of 3,273.59 USD Billion in the year 2024.
    • Small Cell Lung Cancer is the Fastest growing segment in Global Lung Cancer Diagnostics Market to 2032 with a Growth rate of 10.46 % in forecast period 2025-2032.
  • Global Lung Cancer Diagnostics Market to 2032, By Distribution Channel
    • Direct Tender is the largest segment in Global Lung Cancer Diagnostics Market to 2032 with a revenue of 2,378.41 USD Billion in the year 2024.
    • Retail Sales is the Fastest growing segment in Global Lung Cancer Diagnostics Market to 2032 with a Growth rate of 7.92 % in forecast period 2025-2032.
  • Global Lung Cancer Diagnostics Market to 2032, By End User
    • Hospital is the largest segment in Global Lung Cancer Diagnostics Market to 2032 with a revenue of 1,131.39 USD Billion in the year 2024.
    • Hospital is the Fastest growing segment in Global Lung Cancer Diagnostics Market to 2032 with a Growth rate of 17.75 % in forecast period 2025-2032.
  • Global Lung Cancer Diagnostics Market to 2032, By Product
    • Instruments is the largest segment in Global Lung Cancer Diagnostics Market to 2032 with a revenue of 2,711.47 USD Billion in the year 2024.
    • Instruments is the Fastest growing segment in Global Lung Cancer Diagnostics Market to 2032 with a Growth rate of 16.65 % in forecast period 2025-2032.

Global Lung Cancer Diagnostics Market Company Share Analysis

 
Company Name Company Share Analysis
Thermo Fisher Scientific Inc.
Quest Diagnostics Incorporated
Bio-Rad Laboratories, Inc.
Abbott
Guardant Health
Global Lung Cancer Diagnostics Market Company Share Analysis

Global Lung Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Billion

Global Lung Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Billion

Global Lung Cancer Diagnostics Market Company Profiling

Global Lung Cancer Diagnostics Market Company Profiling

Industry Related Reports

Global Cleanroom Technology Market
Global Cochlear Implant Market
Global Chronic Diseases Management Market
Global Hospital Furniture Market
Global Human Fibrin Glue Market
Global Healthcare 3D Printing Market
Global Hydrocephalus Market
Global Intraoperative Radiation Therapy Market
Global Surgical Power Tools Market
Global Inorganic Scintillators Market
Frequently Asked Questions
The Global Lung Cancer Diagnostics Market is segmented based on Segmentation Test,Cancer,Distribution Channel,End User,Product.
Global Lung Cancer Diagnostics Market was valued at USD 4,256.32(Revenue in USD Billion) in 2021.
Global Lung Cancer Diagnostics Market is projected to grow at a CAGR of 15.96% during the forecast period of 2024 to 2032.
The Non-Small Cell Lung Cancer segment is expected to dominate the Global Lung Cancer Diagnostics Market, holding a largest market share of 3,273.59 USD Billion in 2024

Global Lung Cancer Diagnostics Market Scope

Global Lung Cancer Diagnostics Market Segmentation & Scope
Test
  • Blood Test
  • Biopsy
  • Biomarkers Test
  • Others
  • Imaging Test
Cancer
  • Small Cell Lung Cancer
  • Non-Small Cell Lung Cancer
Distribution Channel
  • Retail Sales
  • Direct Tender
End User
  • Others
  • Cancer Research Institutes
  • Diagnostic Imaging Centers
  • Independent Diagnostic Laboratories
  • Associated Labs
  • Hospital
Product
  • Instruments
  • Consumables & Accessories
Frequently Asked Questions
The Global Lung Cancer Diagnostics Market is segmented based on Segmentation Test,Cancer,Distribution Channel,End User,Product.
Global Lung Cancer Diagnostics Market was valued at USD 4,256.32(Revenue in USD Billion) in 2021.
Global Lung Cancer Diagnostics Market is projected to grow at a CAGR of 15.96% during the forecast period of 2024 to 2032.
The estimated market value of the Global Lung Cancer Diagnostics Market for final year is USD 12,992.36 (USD Billion).

Global Lung Cancer Diagnostics Market Company Profiling

Global Lung Cancer Diagnostics Market Company Profiling
Frequently Asked Questions
The Global Lung Cancer Diagnostics Market is segmented based on Segmentation Test,Cancer,Distribution Channel,End User,Product.
Global Lung Cancer Diagnostics Market was valued at USD 4,256.32(Revenue in USD Billion) in 2021.
Global Lung Cancer Diagnostics Market is projected to grow at a CAGR of 15.96% during the forecast period of 2024 to 2032.
The estimated market value of the Global Lung Cancer Diagnostics Market for final year is USD 12,992.36 (USD Billion).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.

BROWSE RELATED PAGES